Subscribe to the News-Journal RSS Feed Mobile Access E-Newsletter Log In or Register as a New User 
Classifieds
Automotive
Real Estate
Employment
Merchandise
HEALTH
HealthDay | Archives

Health News Archives

Diabetes Drugs

New Diabetes Drug Works Well in Trial
Could be approved for U.S. market by next year, researcher says

Drug Fights Diabetic Eye Disease
Retinopathy is a potentially blinding complication, but Atacand may help

Diabetics Less Likely to Lose Weight After Gastric Bypass
Study finds change in med use, improper stomach pouch size are likely causes

Once-Weekly Diabetes Drug Boosts Blood Sugar Control
But Byetta has also been linked recently to patient deaths

Newer Blood Pressure Drug Better for Some Heart Patients, Diabetics
Study found telmisartan offered slight benefit for those unable to take ACE inhibitors

Laser Therapy as Good as Drugs for Diabetic Eye Problems
Had fewer side effects than corticosteroids, study finds

New Spanish Consumer Guide Compares Diabetes Meds
Publication aimed at assisting the 1 in 8 Hispanics with type 2 disease

New Molecular Trigger Described for Hypertension, Diabetes
Out-of-control enzymes do damage in both conditions, study finds

New Antioxidant Drug Shows Promise Against Diabetes
But more studies on cardiovascular risks needed, report says

Cutting Phosphate May Protect Kidney Patients From Heart Trouble
High levels are major source of cardiovascular death risk in those with chronic disease

Next >

HELPFUL TOOLS

Analyze Yourself

Calculate your body mass.
Analyze yourself for depression.
Rate yourself for thyroid disease.
Do you have a sinus infection?



 

Nacogdoches News | Nacogdoches Weather | Sports | Life | Business News | Opinions | Classifieds | Sitemap
Nacogdoches Cars | Nacogdoches Real Estate | Nacogdoches Jobs

Copyright 2008 The Daily Sentinel. All rights reserved. - The Daily Sentinel - Our Partners

By using this service, you accept the terms of our visitor agreement and privacy policy.
Registered site users, you may edit your profile.
Having trouble? Visit our help & FAQ.